Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 19051-19060 Newer>

The Motley Fool December 11, 2006 Anders Bylund	Foolish Forecast: What's Bothering ADC? The telecommunications equipment maker and S&P 500 component is set to report earnings for the fourth-quarter and full fiscal year 2006. Here's what investors ought to know.
The Motley Fool December 11, 2006 S.J. Caplan	Scouting the Latest IPOs Investing in new IPOs holds the potential for shining promise and crushing disappointment: Heelys... Allegiant Travel... Aegean Marine Petroleum Network... Penn Virginia GP Holdings... etc.
The Motley Fool December 11, 2006 Brian Lawler	Weighing In on Sanofi's Acomplia With the future of Sanofi's two top drugs in the hands of the courts, plus any Acomplia approval subject to the whims of the FDA, investors should wait on the sidelines until these judicial and regulatory decisions have been made.
The Motley Fool December 11, 2006 Will Frankenhoff	Ericsson: Ringing Up the Gains At a recent price of around $39 per share, Ericsson trades at approximately 16 times forward earnings estimates, pretty much in line with its projected growth rate.
The Motley Fool December 11, 2006 David Lee Smith	Cemex's Next Round With nary a private equity firm in sight, Mexican cement manufacturing behemoth Cemex won approval from its shareholders late last week to persist in its hostile offer for Australian building materials producer Rinker Group.
The Motley Fool December 11, 2006 Brian Lawler	Biovail Gives Investors the Cash Regardless of lower forward estimates, though, it's nice to see a mature biotech rewarding shareholders, and if Biovail can sustain its dividend over the long run, it will be by far the highest-yielding mid-cap pharma stock.
The Motley Fool December 11, 2006 Brian Lawler	Acorda Calls for 2 More Trials It'll be awhile before the FDA makes its decision on the pharma's new MS drug and the stock price settles down.
The Motley Fool December 11, 2006 Matthew Crews	Rite Aid: Comps Mean Competition The pharmacy chain reported positive same-store results for November. Investors, take note.
The Motley Fool December 11, 2006 Brian Lawler	Another Go for Encysive Drug Trials Sometimes shares of small specialty-pharma stocks rise and fall much more than warranted on every piece of news, and this appears to have happened to Encysive Pharmaceuticals.
The Motley Fool December 11, 2006 Stephen Ellis	Best Buy Plays Santa's Helper The consumer electronics giant offers gift advice for your loved ones. But would Best Buy stock make a useful addition to an investor's gift bag?
<Older 19051-19060 Newer> Return to current articles.